Trial intelligence / Profile preview

Tacrolimus in PM/DM with Interstitial Pneumonitis

NCT00504348Phase 3Completed

Sponsor
Tokyo Medical and Dental University
Start
Jul 2007
Primary completion
Jan 2011
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tacrolimus in polymyositis (PM), dermatomyositis (DM), interstitial pneumonitis, sponsored by Tokyo Medical and Dental University. Started Jul 2007; status: completed.

02

Drugs

tacrolimus
03

Conditions

polymyositis (PM)dermatomyositis (DM)interstitial pneumonitis

Beyond the preview

Go deeper on NCT00504348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00504348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call